1 domain / 2 areas / 1 specialization
BVF Partners
Data updated
BVF Partners L.P. is a private investment manager based in San Francisco, California. Public filings and market data describe it as an SEC-registered investment adviser and biotechnology-focused investor, rather than a broad consumer or software venture fund.
In the psychedelic ecosystem, BVF Partners matters mainly as a healthcare and drug-development capital provider whose investment style aligns more with life sciences than with lifestyle psychedelics. Publicly available sources point to biotech as its core theme, which makes it potentially relevant to companies developing regulated therapeutic compounds and clinical-stage programs.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.
BVF Partners appears to be a San Francisco-based biotechnology investor with a public footprint centered on life sciences and regulated drug development. Its website lists a San Francisco office, and public market disclosures describe it as a biotechnology-focused investor, which makes it relevant to psychedelic companies pursuing clinical, IP-driven therapeutics rather than consumer-facing products. I did not find a public psychedelics-specific investment announcement tied directly to BVF Partners in the sources reviewed.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- HQ
- 44 Montgomery Street, 40th Floor, San Francisco, CA 94104, United States
- Website
- Visit